Search Results 551-560 of 17136 for treatment resistant depression
Alisertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant eligibility ...
Clinical Trials · A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma · More ...
... resistant prostate cancer. BAY 1895344 Plus ... depression, and fatigue among patients with solid ... drug plus standard treatment more effective than standard ...
Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom ...
About this study. Panobinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying ...
Many people with addictions also have depression, anxiety, bipolar disorder or other mental health disorders. Mayo Clinic incorporates treatment for mental ...
The purpose of this study is to determine the proportion of confirmed responses (complete response, partial response), and hematologic improvement as defined by ...
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter.
Age ≥ 18 years. · Must have RRMM after having received prior exposure to at least 3 prior lines of therapies in addition to being refractory to a Proteasome ...
Medication status and prior treatment resistance ... treatment of depression in adults. However, the ... treated for major depression. Lewis CP. Charles ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.